Investing.com - Applied Genetic reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Applied Genetic announced earnings per share of $-0.360 on revenue of $325.0K. Analysts polled by Investing.com anticipated EPS of $-0.334 on revenue of $0.00.
Applied Genetic shares are down 67.82% from the beginning of the year, still down 90.91% from its 52 week high of $3.19 set on September 29, 2021.
Applied Genetic follows other major Healthcare sector earnings this month
Applied Genetic's report follows an earnings beat by Merck ADR on September 9, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Veeva Systems A had beat expectations on August 31 with second quarter EPS of $1.03 on revenue of $534.22M, compared to forecast for EPS of $1.01 on revenue of $530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar